Common Contracts
12 similar null contracts by Biocept Inc, Intrinsic Medicine, Inc., Longboard Pharmaceuticals, Inc., Genelux Corp
BIOCEPT, INC.Biocept Inc • April 17th, 2023 • Services-medical laboratories
Biocept, Inc. (the “Company”) is pleased to offer you at-will employment in the position of Chief Legal and Compliance Officer (“CLO”) on the terms and conditions set forth in this letter agreement (the “Agreement”).
September 9, 2022 Douglas Samuelson, CPA (inactive)Genelux Corp • January 10th, 2023 • Pharmaceutical preparations
Genelux Corporation (the “Company”) is pleased to offer you at-will employment in the position of Vice President, Finance on the terms and conditions set forth in this letter agreement (this “Agreement”).
September 29, 2021 Mr. Sean RyderGenelux Corp • January 10th, 2023 • Pharmaceutical preparations
Genelux Corporation (the “Company”) is pleased to offer you at-will employment in the position of General Counsel and Corporate Secretary on the terms and conditions set forth in this letter agreement (this “Agreement”).
INTRINSIC MEDICINE, INC.Intrinsic Medicine, Inc. • April 8th, 2022 • Biological products, (no disgnostic substances)
Intrinsic Medicine, Inc. (the “Company”) is pleased to offer you continuing at-will employment in the position of Chief Medical Officer on the terms and conditions set forth in this letter agreement (the “Agreement”).
INTRINSIC MEDICINE, INC.Intrinsic Medicine, Inc. • April 8th, 2022 • Biological products, (no disgnostic substances)
Intrinsic Medicine, Inc. (the “Company”) is pleased to offer you continuing at-will employment in the position of General Counsel, Vice President, Legal & Corporate Development and Secretary on the terms and conditions set forth in this letter agreement (the “Agreement”).
INTRINSIC MEDICINE, INC.Intrinsic Medicine, Inc. • April 8th, 2022 • Biological products, (no disgnostic substances)
Intrinsic Medicine, Inc. (the “Company”) is pleased to offer you continuing at-will employment in the position of Chief Executive Officer on the terms and conditions set forth in this letter agreement (the “Agreement”).
BIOCEPT, INC.Biocept Inc • March 8th, 2022 • Services-medical laboratories
Biocept, Inc. (the “Company”) is pleased to offer you at-will employment in the position of Chief Operations Officer (“COO”) on the terms and conditions set forth in this letter agreement (the “Agreement”).
BIOCEPT, INC.Biocept Inc • February 16th, 2022 • Services-medical laboratories
Biocept, Inc. (the “Company”) is pleased to offer you at-will employment in the position of Interim Chief Financial Officer (“Interim CFO”) on the terms and conditions set forth in this letter agreement (the “Agreement”).
BIOCEPT, INC.Biocept Inc • February 16th, 2022 • Services-medical laboratories
Biocept, Inc. (the “Company”) is pleased to offer you at-will employment in the position of Interim Chief Executive Officer (“Interim CEO”) on the terms and conditions set forth in this letter agreement (the “Agreement”).
Longboard Pharmaceuticals, Inc.Longboard Pharmaceuticals, Inc. • March 8th, 2021 • Pharmaceutical preparations
You are currently employed by Longboard Pharmaceuticals, Inc. (the “Company”) under the terms of an offer letter between you and the Company dated January 15, 2021 (the “Offer Letter”). The Company is amending and restating the terms of the Offer Letter to reflect your continued employment terms as set forth in this employment agreement (the “Agreement”). Provided you accept this Agreement by signing and returning it to the Company, this Agreement will become effective as of the date of the underwriting agreement between the Company and the underwriter(s) managing the initial public offering of the Company’s common stock, pursuant to which such common stock is priced for the initial public offering (the “IPO Date”) and upon such IPO Date, shall supersede and replace your Offer Letter in its entirety, and this Agreement shall then govern the terms of your employment with the Company.
Longboard Pharmaceuticals, Inc.Longboard Pharmaceuticals, Inc. • March 8th, 2021 • Pharmaceutical preparations
You are currently employed by Longboard Pharmaceuticals, Inc. (the “Company”) under the terms of an offer letter between you and the Company dated October 27, 2020 (the “Offer Letter”). The Company is amending and restating the terms of the Offer Letter to reflect your continued employment terms as set forth in this employment agreement (the “Agreement”). Provided you accept this Agreement by signing and returning it to the Company, this Agreement will become effective as of the date of the underwriting agreement between the Company and the underwriter(s) managing the initial public offering of the Company’s common stock, pursuant to which such common stock is priced for the initial public offering (the “IPO Date”) and upon such IPO Date, shall supersede and replace your Offer Letter in its entirety, and this Agreement shall then govern the terms of your employment with the Company.
Longboard Pharmaceuticals, Inc.Longboard Pharmaceuticals, Inc. • March 8th, 2021 • Pharmaceutical preparations
You are currently employed by Longboard Pharmaceuticals, Inc. (the “Company”) under the terms of an offer letter between you and the Company dated November 6, 2020 (the “Offer Letter”). The Company is amending and restating the terms of the Offer Letter to reflect your continued employment terms as set forth in this employment agreement (the “Agreement”). Provided you accept this Agreement by signing and returning it to the Company, this Agreement will become effective as of the date of the underwriting agreement between the Company and the underwriter(s) managing the initial public offering of the Company’s common stock, pursuant to which such common stock is priced for the initial public offering (the “IPO Date”) and upon such IPO Date, shall supersede and replace your Offer Letter in its entirety, and this Agreement shall then govern the terms of your employment with the Company.
